GlassScriptPhysician profile
Mariam S Sauer
NPI 1184882227
$2,056.14
in general payments reported to CMS, 2019-2025
20 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.26 · 2020: $104 · 2021: $166 · 2022: $703 · 2023: $412 · 2024: $310 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $877.44 | 2021-2025 | Skyrizi, Rinvoq |
| Boston Scientific Corporation | $292.70 | 2022-2025 | Axonics, Axios |
| Medtronic, INC. | $169.11 | 2022-2024 | Interstim |
| Genzyme Corporation | $117.14 | 2024 | |
| Romark Laboratories, Lc | $104.09 | 2020 | |
| Celgene Corporation | $92.45 | 2021-2023 | |
| Pentax of America, INC. | $91.34 | 2021-2025 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Cook Medical LLC | $58.58 | 2022-2023 | Hemospray, Echotip |
| Merck Sharp & Dohme LLC | $41.40 | 2022 | |
| Pfizer INC. | $32.45 | 2019-2022 | |
| Ardelyx, INC. | $30.24 | 2022-2023 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.65 | 2021-2022 | |
| Redhill Biopharma INC. | $29.64 | 2021 | |
| Nestle Healthcare Nutrition INC. | $19.51 | 2021 | |
| Amgen INC. | $15.14 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $14.64 | 2019 | |
| Ironwood Pharmaceuticals, INC | $14.42 | 2021 | |
| Janssen Biotech, INC. | $13.33 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.87 | 2023 | Entyvio |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariam Sauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.